| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.078 | 0.1 |